Michael Rice
Founder at LifeSci Capital LLC
Net worth: - $ as of 2024-03-30
Profile
Michael Yehuda Rice is the founder of LifeSci Index Partners LLC (founded in 2014), DJE Advisors LLC (founded in 2008), LifeSci Advisors LLC (founded in 2010), and LifeSci Capital LLC (founded in 2013).
He holds the title of Managing Partner at DJE Advisors LLC, Partner at LifeSci Advisors LLC, and Chief Operating Officer at LifeSci Capital LLC.
Mr. Rice is also the founder of LifeSci Partners.
He currently holds positions as Director at Aspargo Laboratories, Inc., Chief Operating Officer & Director at LifeSci Acquisition III Corp., Independent Director at Notable Labs Ltd., Partner at LifeSci Venture Partners, Partner at Lifesci Venture Management LLC, and Member at LifeSci Communications LLC.
In the past, Mr. Rice held positions as Managing Director at Bear, Stearns & Co., Inc., Managing Director at Bank of America Corp., Independent Director at Navidea Biopharmaceuticals, Inc., Managing Director at JPMorgan Chase & Co., Managing Director at ThinkEquity Partners, Director at IASO Pharma, Inc., Managing Director at Banc of America Capital Management LLC, Managing Director at JPMorgan Trust Co. NA, Managing Director at Alex.
Brown & Sons, Inc., Managing Director at Hambrecht & Quist LLC, Managing Director at Bank of America, NA (Charlotte, North Carolina), Independent Non-Executive Director at Vascular Biogenics Ltd., Director at Altimmune, Inc., Director at RDD Pharma Ltd., Independent Director at 9 Meters Biopharma, Inc., Managing Director at ThinkEquity LLC (New York), Independent Director at Chardan Healthcare Acquisition Corp., Chief Operating Officer & Director at LifeSci Acquisition Corp., Independent Director at Chardan Healthcare Acquisition 2 Corp., and Chief Operating Officer & Director at Lifesci Acquisition II Corp.
He also served as Co-Head-Health Care Investment Banking at Canaccord Adams, Inc.Mr. Rice obtained his undergraduate degree from the University of Maryland.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
9 METERS BIOPHARMA, INC.
0.03% | 2023-04-23 | 3,943 ( 0.03% ) | - $ | 2024-03-30 |
-.--% | 2024-01-23 | 0 ( -.--% ) | - $ | 2024-03-30 |
Michael Rice active positions
Companies | Position | Start |
---|---|---|
LifeSci Capital LLC
LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank that offers financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The private company is based in New York, NY. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. LifeSci Capital's highly regarded team of analysts generates differentiated, proprietary research and covers companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Andrew Ian McDonald has been the CEO since 2013. | Founder | 2013-03-13 |
LifeSci Index Partners LLC
LifeSci Index Partners LLC Investment ManagersFinance LifeSci Index Partners LLC (LSIP) is an independent investment advisor headquartered in New York City. The firm was co-founded by Paul Yook, Andrew McDonald and Michael Rice in 2014. LSIP is an index provider of healthcare-based stock market indices and also serves as the investment sub-advisor for the BioShares exchange traded funds. | Founder | 2014-05-31 |
LifeSci Advisors LLC
LifeSci Advisors LLC Miscellaneous Commercial ServicesCommercial Services LifeSci Advisors LLC is an investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. Their services are designed to increase clients? visibility within the investment community and to educate investors about the opportunity. | Founder | 2010-02-28 |
Lifesci Venture Management LLC | Corporate Officer/Principal | - |
LifeSci Venture Partners
LifeSci Venture Partners Investment ManagersFinance LifeSci Venture Partners (LifeSci Venture) is a venture capital subsidiary of LifeSci Index Partners LLC founded in 2017 by Paul Inho Yook. The firm is headquartered in New York. | Private Equity Investor | - |
Aspargo Laboratories, Inc.
Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ. | Director/Board Member | - |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Chief Operating Officer | - |
Lifesci Communications LLC | Corporate Officer/Principal | - |
Former positions of Michael Rice
Companies | Position | End |
---|---|---|
NOTABLE LABS, LTD. | Director/Board Member | 2023-10-15 |
░ ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Michael Rice
University of Maryland | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
NAVIDEA BIOPHARMACEUTICALS, INC. | Health Technology |
JPMORGAN CHASE & CO. | Finance |
9 METERS BIOPHARMA, INC. | Health Technology |
Private companies | 27 |
---|---|
Bear, Stearns & Co., Inc.
Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Bear, Stearns & Co., Inc. is a global investment banking, securities trading and brokerage firm located in New York City with additional offices in Dallas, Boston and San Francisco. The firm is a subsidiary Bear Sterns Cos., Inc. (NYSE: BSC). Their equity research team consists of senior analysts located throughout the world. In addition to domestic coverage, they have research teams focusing on Latin America, Asia and Europe. The analysts use a bottom-up approach to stock selection. The Bear Stearns fixed-income research department provides coverage of every sector of the fixed-income universe. The financial analytics and structured transactions group (F.A.S.T) provides investment research, fixed-income portfolio management and analytical systems, trading technology and general financial expertise. The group also provides a broad range of services to financial institutions including asset-liability management, balance sheet restructuring, receivables-based financing analysis, security and portfolio analysis, peer analysis, and historical and real-time market-based information. | Finance |
Canaccord Adams, Inc.
Canaccord Adams, Inc. Investment Banks/BrokersFinance Canaccord Adams, Inc. is an independent financial services firm and broker/dealer headquartered in Boston with additional offices in New York City, San Francisco, Evanston, Illinois and Houston, Texas. The firm provides research to help clients make informed investment decisions. Their analysts seek to identify opportunities and expose risk with a focus on emerging and small- to mid-cap growth companies. Canaccord Adams focuses on seven sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. The seven sectors they focus on are: metals and mining, energy, technology, life sciences, real estate and gaming, consumer and industrial growth. Canaccord Adams is a subsidiary of Vancouver-based Canaccord Financial, Inc. They are a member of the NASD and the SIPC. | Finance |
ThinkEquity Partners
ThinkEquity Partners Investment ManagersFinance Headquartered in San Francisco with additional offices in New York City, Minneapolis, Chicago and Boston, ThinkEquity Partners is a broker/dealer. The firm offers targeted research and investment banking services for institutional investors and corporate clients. They specialize in identifying, analyzing and understanding the technological, macroeconomic and cultural trends that impact key growth verticals, with a particular concentration on healthcare, technology, media/education and business/consumer services. The firm starts with a top-down analysis approach and then allocates resources based on a long-range research roadmap. | Finance |
IASO Pharma, Inc.
IASO Pharma, Inc. Pharmaceuticals: MajorHealth Technology IASO Pharma, Inc. operated as a development stage biopharmaceutical company which focused on acquiring, developing and commercializing drugs for the treatment and prevention of infectious diseases and other serious illnesses. The company was founded on October 5, 2006 and is headquartered in San Diego, CA. | Health Technology |
Banc of America Capital Management LLC | Finance |
JPMorgan Trust Co. NA | Finance |
Alex. Brown & Sons, Inc. | Finance |
Hambrecht & Quist LLC | Finance |
Bank of America, NA (Charlotte, North Carolina)
Bank of America, NA (Charlotte, North Carolina) Major BanksFinance Bank of America, NA engages in the provision of commercial banking services. It offers financing, checking and savings accounts, and investment banking for individual clients. The company was founded on March 1, 1927 and is headquartered in Charlotte, NC. | Finance |
Vascular Biogenics Ltd.
Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
Altimmune, Inc. /Old/
Altimmune, Inc. /Old/ Medical/Nursing ServicesHealth Services Altimmune, Inc. develops vaccines and other biological products. The firm offers products for use in companion and commercial livestock, including cats, dogs, horses, swine, poultry and aquaculture. The company was founded by G. Michael Alder and De-chu Tang in 1997 and is headquartered in Gaithersburg, MD. | Health Services |
RDD Pharma Ltd.
RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Health Technology |
DJE Advisors LLC
DJE Advisors LLC Investment ManagersFinance DJE Advisors LLC is an independent hedge fund manager headquartered in Englewood, New Jersey. Founded in 2008, the firm provides investment advisory and management services to high-net-worth clients. | Finance |
LifeSci Advisors LLC
LifeSci Advisors LLC Miscellaneous Commercial ServicesCommercial Services LifeSci Advisors LLC is an investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. Their services are designed to increase clients? visibility within the investment community and to educate investors about the opportunity. | Commercial Services |
LifeSci Capital LLC
LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank that offers financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The private company is based in New York, NY. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. LifeSci Capital's highly regarded team of analysts generates differentiated, proprietary research and covers companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Andrew Ian McDonald has been the CEO since 2013. | Finance |
LifeSci Index Partners LLC
LifeSci Index Partners LLC Investment ManagersFinance LifeSci Index Partners LLC (LSIP) is an independent investment advisor headquartered in New York City. The firm was co-founded by Paul Yook, Andrew McDonald and Michael Rice in 2014. LSIP is an index provider of healthcare-based stock market indices and also serves as the investment sub-advisor for the BioShares exchange traded funds. | Finance |
LifeSci Venture Partners
LifeSci Venture Partners Investment ManagersFinance LifeSci Venture Partners (LifeSci Venture) is a venture capital subsidiary of LifeSci Index Partners LLC founded in 2017 by Paul Inho Yook. The firm is headquartered in New York. | Finance |
ThinkEquity LLC (New York)
ThinkEquity LLC (New York) Investment ManagersFinance Part of Fordham Holdings Group, Inc., ThinkEquity LLC is a financial services company based in New York, NY. The private company's model is centered around meeting the needs of its clients by assisting them in managing risk, enhancing their performance, and decreasing overall transaction costs. | Finance |
Chardan Healthcare Acquisition Corp.
Chardan Healthcare Acquisition Corp. Financial ConglomeratesFinance Chardan Healthcare Acquisition Corp. is a blank check company, which engages in seeking and acquiring one or more growth businesses. It focuses on businesses that have their primary operations located in North America in the healthcare industry. The company was founded on November 1 , 2017 and is headquartered in New York, NY. | Finance |
LifeSci Acquisition Corp.
LifeSci Acquisition Corp. Financial ConglomeratesFinance LifeSci Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
Aspargo Laboratories, Inc.
Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Chardan Healthcare Acquisition 2 Corp.
Chardan Healthcare Acquisition 2 Corp. Financial ConglomeratesFinance Chardan Healthcare Acquisition 2 Corp. operates as a blank check company, which engages in the acquisition of healthcare company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on December 19, 2018 and is headquartered in New York, NY. | Finance |
Lifesci Venture Management LLC | |
Lifesci Acquisition II Corp.
Lifesci Acquisition II Corp. Financial ConglomeratesFinance LifeSci Acquisition II Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses for its initial business. The company was founded on December 18, 2019 and is headquartered in New York, NY. | Finance |
Lifesci Communications LLC | |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Finance |
LifeSci Partners |
- Stock Market
- Insiders
- Michael Rice